ABT insider trading
NYSE HealthcareABBOTT LABORATORIES — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About ABBOTT LABORATORIES
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. The company also provides cancer screening and diagnostic test products. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
Company website: www.abbott.com
ABT insider activity at a glance
FilingIQ has scored 2,563 insider transactions for ABT since Jun 3, 2014. The most recent filing in our index is dated Apr 28, 2026.
Across the full history, 356 open-market purchases
and 1,136 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ABT insider trades is 56.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ABT Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading ABT
13F funds holding ABT
Politicians who have traded ABT
Frequently asked
- How many insider trades does FilingIQ track for ABT?
- FilingIQ tracks 2,563 Form 4 insider transactions for ABT (ABBOTT LABORATORIES), covering filings from Jun 3, 2014 onwards. 61 of those were filed in the last 90 days.
- Are ABT insiders net buyers or net sellers?
- Across the full Form 4 history for ABT, 356 transactions (14%) were open-market purchases and 1,136 (44%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ABT insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is ABT in?
- ABBOTT LABORATORIES (ABT) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $163.92B.
Methodology & sources
Every ABT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.